Companies / Echo Therapeutics, Inc.
Echo Therapeutics, Inc.
ECTECIK 1031927
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 20, 2015 | Hollander Scott Wayne CEO | Buy Open-market buy | Common Stock | $11.8K | +8K | 8,000 | low |
| May 20, 2015 | Schoenbart Alan Wayne Executive | Buy Open-market buy | Common Stock | $3.6K | +3K | 2,500 | low |
| Dec 18, 2014 | Nordlicht Mark 10% owner | Other Other (per filing) | Series F Preferred Stock | — | +448K | 447,590 | low |
| Dec 18, 2014 | Nordlicht Mark 10% owner | Other Other (per filing) | Series F Preferred Stock | — | +1.1M +250.47% | 1,472,578 | low |
| Dec 18, 2014 | Nordlicht Mark 10% owner | Buy Open-market buy | Warrants | — | +1 | 1 | low |
| Dec 18, 2014 | Nordlicht Mark 10% owner | Buy Open-market buy | Series F Preferred Stock | — | +420K | 420,168 | low |
| Dec 18, 2014 | Nordlicht Mark 10% owner | Other Other (per filing) | Common Stock | — | -448K -62.15% | 272,603 | low |
| Dec 18, 2014 | Nordlicht Mark 10% owner | Other Other (per filing) | Common Stock | — | -1.1M -67.30% | 511,273 | low |